NCT02679664View on ClinicalTrials.gov

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

PHASE2UnknownINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 13, 2020

Study Completion Date

July 31, 2020

Conditions
Venous Thromboembolism
Interventions
DRUG

Rosuvastatin

20 mg tablet of rosuvastatin

Trial Locations (6)

Unknown

Nova Scotia Health Authority, Halifax

Hamilton Health Sciences Corporation, Hamilton

Lawson Health Research Institute, London Health Sciences Centre, London

Ottawa Hospital, Ottawa

Sir Mortimer B. Davis Jewish General Hospital, Montreal

Østfold Hospital Trust, Grålum

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER